Rani Therapeutics
A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies
7
Funding Rounds
$529.0m
Money raised
Overview
A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi* Im*** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi* Im*** |
|
- | - |
| Ta*** Im*** | - | - | |
| An**** Fa**** | - | - | |
| Ly* Ba*** | - | - | |
| Ma**** Na* | - | - | |
| Je* Bu*** | - | - | |
| La De | - | - | |
| De**** Au* | - | - | |
| Li** Ro | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi* Im*** |
|
- | - |
| Ta*** Im*** | - | - | |
| Sv** Sa | - | - |
Funding
Funding series
Funding Series Analysis
The company Rani Therapeutics has raised a total of $332m in funding over 7 rounds.
Key Insights:
- Rani Therapeutics Venture round: $220m
- Rani Therapeutics Initial public offering (IPO): $73m
- Rani Therapeutics Series D round, September 2017: $39m
- Rani Therapeutics funding round, February 2018: $53m
- Rani Therapeutics, LLC funding round, November 2020: $75m
- Rani Therapeutics Series E round December 2020: $69m
Rani Therapeutics Venture round
$220m
Rani Therapeutics Initial public offering (IPO)
$73m
Rani Therapeutics Series D round, September 2017
$39m
Rani Therapeutics funding round, February 2018
$53m
Rani Therapeutics, LLC funding round, November 2020
$75m
Rani Therapeutics Series E round December 2020
$69m
Industries
Rani Therapeutics is active in the following industries: